{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:13:30Z","timestamp":1769573610061,"version":"3.49.0"},"reference-count":60,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cystinosis is a very rare autosomal recessive lysosomal storage disorder with an incidence of 1\u200a:\u200a150,000\u200a\u2013\u200a1\u200a:\u200a200,000, and is caused by mutations in the CTNS gene encoding the lysosomal membrane protein cystinosin, which transports cystine out of the lysosome into the cytoplasm. As a result, accumulation of cystine occurs in almost all cells and tissues, especially in the kidneys, leading to multiple organ involvement. Introduction of drug therapy with cysteamine in the mid 1980s, along with the availability of renal replacement therapy in childhood, have dramatically improved patient outcome. Whereas patients used to die without therapy with end-stage renal failure during the first decade of life, nowadays most patients live well into adulthood without renal replacement therapy, and several reach 40 years. There is robust evidence that early initiation and sustained lifelong therapy with cysteamine are both essential for morbidity and mortality. The rarity of the disease\n          and the multi-organ involvement present an enormous challenge for those affected and the providers of care for this patient group.<\/jats:p>","DOI":"10.1055\/a-2022-8522","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T19:00:35Z","timestamp":1680030035000},"page":"251-259","source":"Crossref","is-referenced-by-count":2,"title":["Cystinosis"],"prefix":"10.1055","volume":"240","author":[{"given":"Katharina","family":"Hohenfellner","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kinder- und Jugendmedizin\/Kindernephrologie, RoMed Kliniken, Rosenheim, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirstin","family":"Zerell","sequence":"additional","affiliation":[{"name":"Rosenheim, kbo-Heckscher-Klinikum gGmbH, M\u00fcnchen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr P\u00e4diatrische Nieren-, Leber- & Stoffwechselerkrankungen, MHH, Hannover, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"ref1","first-page":"557","article-title":"Famili\u00e4re Cystindiathese","volume":"38","author":"E Abderhalden","year":"1903","journal-title":"Z Biol Chem"},{"key":"ref2","first-page":"139","article-title":"\u00dcber St\u00f6rung des Cystinstoffwechsels bei Kindern","volume":"145","author":"G OE Lignac","year":"1924","journal-title":"Dtsch Arch Klin Med"},{"key":"ref3","first-page":"257","article-title":"Die nicht diabetischen Glykosurien und Hyperglykaemien des aelteren Kindes","volume":"133","author":"G Fanconi","year":"1931","journal-title":"Jb Kinderheilkd"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000045518","article-title":"Long-term outcome of paediatric patients with hereditary tubular disorders","volume":"83","author":"D Haffner","year":"1999","journal-title":"Nephron"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"W A Gahl","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1126\/science.7112129","article-title":"Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis","volume":"217","author":"W A Gahl","year":"1982","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-012-2242-5","article-title":"Cystinosis: the evolution of a treatable disease","volume":"28","author":"G Nesterova","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00467-007-0650-8","article-title":"Nephropathic cystinosis: late complications of a multisystemic disease","volume":"23","author":"G Nesterova","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/archopht.1986.01050170096030","article-title":"Long-term ocular manifestations in nephropathic cystinosis","volume":"104","author":"M I Kaiser-Kupfer","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJM198704163161602","article-title":"Cysteamine therapy for children with nephropathic cystinosis","volume":"316","author":"W A Gahl","year":"1987","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/jama.1993.03510180070036","article-title":"Classic nephropathic cystinosis as an adult disease","volume":"270","author":"D S Theodoropoulos","year":"1993","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/0003-4819-147-4-200708210-00006","article-title":"Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy","volume":"147","author":"W A Gahl","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2215\/CJN.01740407","article-title":"Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping","volume":"3","author":"A Servais","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1203\/00006450-200001000-00007","article-title":"Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations","volume":"47","author":"Y Anikster","year":"2000","journal-title":"Pediatr Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"M A Elmonem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000495270","article-title":"Molecular Basis of Cystinosis: Geographic Distribution, Functional Consequences of Mutations in the CTNS Gene, and Potential for Repair","volume":"141","author":"D David","year":"2019","journal-title":"Nephron"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng0498-319","article-title":"A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis","volume":"18","author":"M Town","year":"1998","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.204","article-title":"Clinical utility gene card for: cystinosis","author":"E Levtchenko","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/humu.9063","article-title":"Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis","volume":"20","author":"M Kiehntopf","year":"2002","journal-title":"Hum Mutat"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1086\/302118","article-title":"CTNS mutations in an American-based population of cystinosis patients","volume":"63","author":"V Shotelersuk","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/8904_2013_288","article-title":"Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis","volume":"14","author":"N A Soliman","year":"2014","journal-title":"JIMD Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jmg.35.5.366","article-title":"A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK","volume":"35","author":"A C Hutchesson","year":"1998","journal-title":"J Med Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100514","DOI":"10.1016\/j.ymgmr.2019.100514","article-title":"Molecular based newborn screening in Germany: Follow-up for cystinosis","volume":"21","author":"K Hohenfellner","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1097\/01.asn.0000036867.49866.59","article-title":"Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells","volume":"13","author":"M Park","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1203\/01.pdr.0000196334.46940.54","article-title":"Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts","volume":"59","author":"E N Levtchenko","year":"2006","journal-title":"Pediatr Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"F905","DOI":"10.1152\/ajprenal.00318.2010","article-title":"The pathogenesis of cystinosis: mechanisms beyond cystine accumulation","volume":"299","author":"M J Wilmer","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.15252\/emmm.201404223","article-title":"Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis","volume":"7","author":"G Napolitano","year":"2015","journal-title":"EMBO Mol Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/mgme.2000.3062","article-title":"Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops","volume":"71","author":"W A Gahl","year":"2000","journal-title":"Mol Genet Metab"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/BF00856532","article-title":"Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis","volume":"8","author":"F Manz","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1172\/JCI108448","article-title":"Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo","volume":"58","author":"J G Thoene","year":"1976","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"E3434","DOI":"10.1073\/pnas.1211198109","article-title":"Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy","volume":"109","author":"A J\u00e9z\u00e9gou","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJM199304223281604","article-title":"Improved renal function in children with cystinosis treated with cysteamine","volume":"328","author":"T C Markello","year":"1993","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0885-4505(92)90074-9","article-title":"Parenchymal organ cystine depletion with long-term cysteamine therapy","volume":"48","author":"W A Gahl","year":"1992","journal-title":"Biochem Med Metab Biol"},{"key":"ref34","volume-title":"Cystinosis. 2001 Mar 22, last revision: 2017 Dec 7","author":"G Nesterova"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1750-1172-6-86","article-title":"Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients","volume":"6","author":"N Bouazza","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1365-2125.2003.01927.x","article-title":"Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients","volume":"56","author":"E B Belldina","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2007.04.002","article-title":"The origin of halitosis in cystinotic patients due to cysteamine treatment","volume":"91","author":"M Besouw","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ndt\/gfu329","article-title":"Cysteamine (Cystagon\u00ae) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults","volume":"30","author":"G Ariceta","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1067\/S0022-3476(03)00281-6","article-title":"The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine","volume":"143","author":"R Dohil","year":"2003","journal-title":"J Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jpeds.2011.05.057","article-title":"Cysteamine toxicity in patients with cystinosis","volume":"159","author":"M TP Besouw","year":"2011","journal-title":"J Pediatr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s004670050467","article-title":"Feeding problems in cystinosis","volume":"12","author":"E Elenberg","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/pl00013448","article-title":"Early development of the renal lesions in infantile cystinosis","volume":"15","author":"C P Mahoney","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jpeds.2004.03.056","article-title":"Long-term follow-up of well-treated nephropathic cystinosis patients","volume":"145","author":"R Kleta","year":"2004","journal-title":"J Pediatr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.kint.2021.06.019","article-title":"An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis","volume":"100","author":"F Emma","year":"2021","journal-title":"Kidney Int"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ymgme.2022.06.009","article-title":"Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis","volume":"136","author":"K Hohenfellner","year":"2022","journal-title":"Mol Genet Metab"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41431-019-0521-3","article-title":"Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis","volume":"28","author":"T Fleige","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ymgme.2022.06.010","article-title":"Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis","volume":"136","author":"C Nie\u00dfl","year":"2022","journal-title":"Mol Genet Metab"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.ajkd.2014.07.020","article-title":"Patient and graft survival following kidney transplantation in recipients with cystinosis: a cohort study","volume":"65","author":"R A Spicer","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJM198812013192206","article-title":"Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis","volume":"319","author":"W A Gahl","year":"1988","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.md.0000164204.00159.d4","article-title":"Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy","volume":"84","author":"B C Sonies","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jpeds.2004.06.080","article-title":"Idiopathic intracranial hypertension in cystinosis","volume":"145","author":"C F Dogulu","year":"2004","journal-title":"J Pediatr"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archneur.1989.00520410077027","article-title":"Neurologic complications in long-standing nephropathic cystinosis","volume":"46","author":"J K Fink","year":"1989","journal-title":"Arch Neurol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jimd.12134","article-title":"Management of bone disease in cystinosis: Statement from an international conference","volume":"42","author":"K Hohenfellner","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/jbmr.3522","article-title":"Skeletal Consequences of Nephropathic Cystinosis","volume":"33","author":"P Florenzano","year":"2018","journal-title":"J Bone Miner Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1067\/mpd.2001.113263","article-title":"Long-term treatment with growth hormone in short children with nephropathic cystinosis","volume":"138","author":"E W\u00fchl","year":"2001","journal-title":"J Pediatr"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/(SICI)1096-9926(199809\/10)58:3\/4<96::AID-TERA5>3.0.CO;2-7","article-title":"Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development","volume":"58","author":"D A Beckman","year":"1998","journal-title":"Teratology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/humrep\/deab030","article-title":"Testicular function in males with infantile nephropathic cystinosis","volume":"36","author":"J Rohayem","year":"2021","journal-title":"Hum Reprod"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.119.2.394","article-title":"Pulmonary dysfunction in adults with nephropathic cystinosis","volume":"119","author":"Y Anikster","year":"2001","journal-title":"Chest"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/s0022-3476(88)80214-2","article-title":"Neurologic and cognitive deficits in children with cystinosis","volume":"112","author":"D A Trauner","year":"1988","journal-title":"J Pediatr"},{"key":"ref60","first-page":"A-1378","article-title":"Spezielle Cystinose-Sprechstunde","volume":"112","author":"K Hohenfellner","year":"2015","journal-title":"Dtsch Arztebl Ausg A"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2022-8522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:32:18Z","timestamp":1758241938000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2022-8522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,3,28]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2022-8522","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}